Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02269 WUXI BIO
RTNominal up13.400 +0.540 (+4.199%)
Others

23/05/2018 09:15

WuXi Bio (02269) plans to build new facility in Singapore

[ET Net News Agency, 23 May 2018] WuXi Biologics (02269) said it plans to establish a
new biologics clinical and commercial manufacturing facility in Singapore.
According to the company's preliminary development plan, it may involve a total
investment amount of about S$80 million (equivalent to about HK$467 million) and hiring of
about 150 employees.
It is intended that the Singapore new facility will be constructed with a total of
4,500L bioreactor capacity, where two 2,000L traditional fed-batch and one 500L perfusion
based continuous processing will be installed for the purpose of handling both clinical
and small volume commercial production. (HL)

Back to Others

Remark: Real time quote last updated: 25/09/2024 18:00
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.